Current Treatment Options in Neurology

Papers
(The TQCC of Current Treatment Options in Neurology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System81
Early Aggressive Treatment Approaches for Multiple Sclerosis47
Treatment of Women with Multiple Sclerosis Planning Pregnancy40
Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease23
COVID-19 and Sleep in Medical Staff: Reflections, Clinical Evidences, and Perspectives23
Treatment Approaches for Functional Neurological Disorders in Children20
Treatment Updates for Neuromuscular Channelopathies19
Dementia Clinical Care in Relation to COVID-1918
Cerebral Edema in Traumatic Brain Injury: a Historical Framework for Current Therapy17
Mobile Stroke Units: Bringing Treatment to the Patient17
One Giant Step for Giant Cell Arteritis: Updates in Diagnosis and Treatment17
Epilepsy in brain metastasis: an emerging entity16
Advances in Targeted Therapies for Pediatric Brain Tumors14
A Literature Systematic Review with Meta-Analysis of Symptoms Prevalence in Covid-19: the Relevance of Olfactory Symptoms in Infection Not Requiring Hospitalization14
Evaluation, Treatment, and Impact of Neurologic Injury in Adult Patients on Extracorporeal Membrane Oxygenation: a Review12
Diagnosis and Management of Seizures in Neurodegenerative Diseases12
Inflammatory Manifestations of Systemic Diseases in the Central Nervous System11
Nutrition in the Neurocritical Care Unit: a New Frontier10
Vascular Events, Vascular Disease and Vascular Risk Factors—Strongly Intertwined with COVID-1910
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview9
Severe Neurologic Complications of SARS-CoV-29
New Therapeutic Landscape in Neuromyelitis Optica9
Controversies in Brain Death Declaration: Legal and Ethical Implications in the ICU9
Harnessing Big Data in Neurocritical Care in the Era of Precision Medicine8
Newer Immunotherapies for the Treatment of Acute Neuromuscular Disease in the Critical Care Unit7
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?7
Pharmacologic and Acute Management of Spinal Cord Injury in Adults and Children7
Myasthenia Gravis Treatment Updates7
Neurocritical Care of the Pregnant Patient6
Stroke Treatment in the Era of COVID-19: a Review6
Brain-Lung Crosstalk: Management of Concomitant Severe Acute Brain Injury and Acute Respiratory Distress Syndrome6
Dizziness and Balance Problems in Children6
Iron Replacement Therapy in Restless Legs Syndrome6
Diagnosis and Management of Cognitive Concerns in the Oldest-Old5
A Review of Adult-Onset Hearing Loss: a Primer for Neurologists5
Secondary Causes of Myositis5
Diagnosis and Management of Posterior Cortical Atrophy5
The Importance and Opportunity for Healthy Aging Through Lifestyle, Behavior Medicine Among Older Adults With Multiple Sclerosis: the Case Based on Physical Activity5
Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas5
Managing the Behavioral and Psychological Symptoms of Dementia4
Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults4
Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review4
Neurologic Manifestations of Systemic Disease: Sleep Disorders4
0.01667594909668